Computerised brain implant reduces pain in NYU Langone’s study
The brain implant is said to be the first of its kind that targets chronic pain, which usually arises without a known trigger.
Treatments
Medtronic obtains expanded FDA approval for cryoablation catheters
The catheters are indicated for treating paroxysmal atrial fibrillation as an early rhythm control strategy.
Medical Tourism: Regulatory Trends
While all countries have their own regulatory bodies that regulate the approval of medical devices...
Organon closes $240m acquisition of Alydia Health
Alydia received $50m of the upfront payment on the signing of the deal and the...
Amalgam Rx obtains CE mark for basal insulin titration app
iSage Rx can be used for the titration of all basal insulins and can be...
Medical Tourism: Macroeconomic Trends
Medical tourism is a key market for both the medical devices industry and the growth of emerging markets.
Medical Tourism: Technology Trends
Medical tourism is sometimes seen as a sub-segment of the larger health and wellness tourism industry, where the purpose of travel is to maintain one’s health and wellbeing.
Abbott obtains CE mark for steerable delivery system for LAA occlusion
Approved for use with Abbott’s Amplatzer Amulet LAA Occluder, the system is only available in Europe and Canada.
Medtronic’s SenSight system for DBS gets FDA approval
The SenSight system can be used to treat symptoms linked to movement disorders such as Parkinson’s disease and epilepsy.
FDA imposes clinical hold on Ortho Regenerative’s implant trial
Ortho plans to submit further chemistry, manufacturing and control related data in the coming weeks.
Philips’ endovascular system yields positive data in TOBA II BTK trial
The implantable device offers continued treatment effect and progressive impact on quality of life in PAD and CLI patients.
